Cereno Scientific AB Logo

Cereno Scientific AB

Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.

CRNO | ST

Overview

Corporate Details

ISIN(s):
SE0008241541 (+3 more)
LEI:
549300VX8KTMYDS6NM84
Country:
Sweden
Address:
BioVentureHub, 431 83 Mölndal
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Cereno Scientific AB is a clinical-stage biotechnology company focused on developing innovative, disease-modifying treatments for rare cardiovascular and pulmonary diseases. The company's pipeline includes drug candidates in both clinical and preclinical phases. Its clinical portfolio utilizes epigenetic modulation through an HDACi (histone deacetylase inhibitor) platform. A key preclinical asset, CS585, is a novel prostacyclin (IP) receptor agonist. Cereno's strategy targets diseases with significant unmet medical needs, aiming to provide high treatment value to patients while leveraging a business model that allows for potentially shorter development timelines and accelerated market entry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cereno Scientific AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cereno Scientific AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cereno Scientific AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-16 Sten Sörensen Other Other 866,665 86,666.50 SEK
2024-11-25 Security Holding Sverige AB Other Buy 20,000 99,800.00 SEK

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.